Monitoring the Size and Response of Locally Advanced Breast Cancers to Neoadjuvant Chemotherapy (Weekly Paclitaxel and Epirubicin) with Serial Enhanced MRI
- 1 March 2003
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 78 (1) , 51-58
- https://doi.org/10.1023/a:1022153327339
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imagingCancer, 1996
- Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy.Radiology, 1994
- Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinomaCancer, 1992
- Multimodal therapy in locally advanced breast carcinomaThe American Journal of Surgery, 1990
- Karnofsky memorial lecture. Conceptual and practical advances in the management of breast cancer.Journal of Clinical Oncology, 1989
- Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapyCancer, 1988
- Advanced primary breast cancer: assessment at mammography of response to induction chemotherapy.Radiology, 1988
- Neoadjuvant Chemotherapy Before Definitive Treatment for Stage III Carcinoma of the BreastArchives of Surgery, 1987
- Problems in evaluating response of primary breast cancer to systemic therapyBreast Cancer Research and Treatment, 1984
- Multimodal treatment of locoregionally advanced breast cancerCancer, 1983